Delivery Order SPE2DB22D3016-SPE2DB25FBCG7
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,239.14 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This non-competitive, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in military and federal healthcare settings for immunization programs across the...
- The Defense Logistics Agency awarded a $1,751.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for ENGERIX-B 20 MCG/ML vaccine syringes. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $3,854.18 to AmerisourceBergen Drug Corp for ENGERIX-B 20 mcg/mL syringes on August 19, 2025, with ultimate completion by August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used across federal healthcare systems to support immunization programs for military personnel, veterans,...
- The Defense Logistics Agency awarded a delivery order valued at $9,476.83 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on August 27, 2025, with completion scheduled for August 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in military and federal healthcare settings...
- The Defense Logistics Agency awarded a delivery order valued at $5,984.54 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used across military and federal healthcare systems to support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,498.00 to supply ENGERIX-B 20 MCG/ML syringes, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in military and veteran healthcare settings, aligning with the Department of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 mcg/mL syringes valued at $2,081.70 under a firm fixed-price contract type. The award, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a competitively awarded, non-set-aside contract. ENGERIX-B is a hepatitis B vaccine product, indicating this delivery supports federal medical supply requirements for military and veteran healthcare systems. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency awarded a $19,926.00 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used across military medical treatment facilities and veteran healthcare systems to support immunization...
- The Defense Logistics Agency awarded a delivery order valued at $1,334.40 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes under a firm fixed price contract. This non-set-aside award was made on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...